GRADE & PURITYAnimal Free?Animal-free — produced without animal-derived components to reduce contamination risk. Use in biomanufacturing and culture avoiding animal-origin material.Carrier Free?Carrier-free — supplied without added carrier protein/stabilizer. Use when carriers (e.g. BSA) would interfere with conjugation or sensitive assays.Recombinant?Recombinant — produced via recombinant expression for defined sequence and consistency. Use for reproducible, animal-free proteins of known origin.Validated?Validated grade — performance confirmed in defined applications before release. Use when you want documented assurance the reagent works as stated.ExactAb™?ExactAb™ — Aladdin's antibody line emphasizing precision and validated quality. Use for reliable, specificity-validated antibody applications.Low Endotoxin?Low-endotoxin grade — endotoxin reduced to low controlled levels. Use in sensitive biological work where high endotoxin would interfere.Azide Free?Azide-free — without sodium azide preservative. Use in conjugations, cell work, or assays where azide is toxic or inhibitory.≥90%(SDS-PAGE&SEC-HPLC)See COA
Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥90%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
🌡
Storage & shipping
Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
📋
Quality documents
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
📚
Literature proof
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Overview
Patritumab deruxtecan (anti-ERBB3) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity. Purity >90% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg
Specifications
Product Name
Patritumab deruxtecan (anti-ERBB3) - Primary antibody, specific to ERBB3, Human IgG1, BINDING AGENT of Receptor tyrosine-protein kinase erbB-3 binding agent
Synonyms
c erbB 3 antibody | c erbB3 antibody | Erb b2 receptor tyrosine kinase 3 antibody | ErbB 3 antibody | ERBB3 antibody | ERBB3 protein antibody | erbB3 S antibody | ERBB3_HUMAN antibody | Glial growth factor receptor antibody | HER 3 antibody | HER3 antibod
Specifications & Purity
Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥90%(SDS-PAGE&SEC-HPLC), See COA
BINDING AGENT of Receptor tyrosine-protein kinase erbB-3 binding agent
Isotype
Human IgG1
Light Chain Type
kappa
SDS-PAGE
146.86 kDa
Purification Method
Protein A purified
Concentration
See COA
CAS
2227102-46-5
Storage and Shipping
Shape
Liquid
Storage
Store at -80°C,Avoid repeated freezing and thawing
Shipped In
Dry ice packs + Cold packs
Stability And Storage
Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
Images
Patritumab deruxtecan (anti-ERBB3) (Ab183315) - Flow Cytometry Flow Cytometry analysis of MCF-7 cells labelling ERBB3 (red) with Patritumab deruxtecan (anti-ERBB3) (Ab183315). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Patritumab deruxtecan (anti-ERBB3) (Ab183315) - Flow Cytometry Flow Cytometry analysis of A431 cells labelling ERBB3 (red) with Patritumab deruxtecan (anti-ERBB3) (Ab183315). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Patritumab deruxtecan (anti-ERBB3) (Ab183315) - ELISA Immobilized Recombinant Human ERBB3 protein (rp170123) at 1.0 μg/mL can bind Patritumab deruxtecan (anti-ERBB3) (Ab183315) with the EC₅₀ of 24.89 ng/mL.
Patritumab deruxtecan (anti-ERBB3) (Ab183315) - SEC The purity of Patritumab deruxtecan (anti-ERBB3) (Ab183315) is more than 95% verified by HPLC.
Documentation
📋 Safety Data Sheet (SDS)
Comprehensive hazard, handling, storage, and regulatory compliance document.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
ZJ24F0607557
